Kerstin F. Gerer

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Dennis Christoph Harrer, Bianca Simon, Shin‐ichiro Fujii et al. · BMC Cancer · 2017 · 109 citations · Full text

Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins

Kerstin F. Gerer, Stefanie Hoyer, Jan Dörrie et al. · Methods in molecular biology · 2016 · 36 citations

Universal Technology Platform, Protein Expression, Natural Sciences +10

Triggering of NF‐κB in cytokine‐matured human DCs generates superior DCs for T‐cell priming in cancer immunotherapy

Isabell A. Pfeiffer, Stefanie Hoyer, Kerstin F. Gerer et al. · European Journal of Immunology · 2014 · 30 citations · Full text

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy

Jan Dörrie, Lek Babalija, Stefanie Hoyer et al. · International Journal of Molecular Sciences · 2018 · 27 citations · Full text

Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination

Kerstin F. Gerer, Michael Erdmann, Sine Reker Hadrup et al. · Therapeutic Advances in Medical Oncology · 2017 · 22 citations · Full text